Moshe is my secret weapon. I met him through Company Ventures early in my pre-seed raise last year. Within 15 minutes of chatting, he had conviction, a rarity. Over the next two weeks, he hustled in every which way possible to help me close the deal early days of the pandemic when most investors were closing shop with the markets in disarray. Over the past 18 months, he has helped bring product and marketing insights from companies that have nothing to do with oncology, like Superhuman, Clubhouse and Haus, to the cancer patient at Alula. His ability to spot early trends, cross-pollinate them and empower founders with insights they hear nowhere else is one-of-a-kind. Oh, and he's the realest!